conbercept
Y-2016020
Approved small_molecule completed
Quick answer
conbercept for Polypoidal Choroidal Vasculopathy is a Approved program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Polypoidal Choroidal Vasculopathy
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed